Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer
Author:
Publisher
Elsevier BV
Subject
Pharmacology,Biochemistry
Reference82 articles.
1. Targeting PI3K signalling in cancer: opportunities, challenges and limitations;Engelman;Nat Rev Cancer,2009
2. Development of PI3K inhibitors: lessons learned from early clinical trials;Rodon;Nat Rev Clin Oncol,2013
3. The phosphatase PHLPP controls the cellular levels of protein kinase C;Gao;J Biol Chem,2008
4. The TSC1-TSC2 complex: a molecular switchboard controlling cell growth;Huang;Biochem J,2008
5. mTOR and cancer: many loops in one pathway;Efeyan;Curr Opin Cell Biol,2010
Cited by 372 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Inhibition of NNMT enhances drug sensitivity in lung cancer cells through mediation of autophagy;Frontiers in Pharmacology;2024-07-05
2. REVOLUTIONIZING LUNG CANCER CARE: THE MULTIFACETED APPROACH OF ARTIFICIAL INTELLIGENCE, LIQUID BIOPSIES, AND CIRCULATING TUMOR DNA IN SCREENING, DIAGNOSIS, AND PROGNOSIS;TURKISH MEDICAL STUDENT JOURNAL;2024-07-03
3. TM6SF1 suppresses the progression of lung adenocarcinoma and M2 macrophage polarization by inactivating the PI3K/AKT/mtor pathway;Biochemical and Biophysical Research Communications;2024-07
4. Cross-attention enables deep learning on limited omics-imaging-clinical data of 130 lung cancer patients;Cell Reports Methods;2024-07
5. Atherosclerosis Is a Smooth Muscle Cell–Driven Tumor-Like Disease;Circulation;2024-06-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3